We recently traveled to Columbus, Ohio for a State of the Science Summit™ on Ovarian Cancer, which featured insights from The Ohio State University Comprehensive Cancer Center–James faculty.
We recently traveled to Columbus, Ohio for a State of the Science Summit™ on Ovarian Cancer. At the meeting, faculty from The Ohio State University Comprehensive Cancer Center—James, discussed the importance of performing genetic testing upon diagnosis, shared insight on the evolution of ovarian cancer therapeutics, and provided perspective on individualized approaches in the frontline setting.
Additionally, panelists highlighted selection criteria for surgical procedures in ovarian cancer, contextualized the role of secondary surgery in the recurrent setting, and shed light on real-world evidence with PARP inhibitors in this space.
Interested in attending an upcoming OncLive® State of the Science Summit™ in your area? Register today.